NEW YORK, Oct. 10 – Qiagen said on Wednesday that it has received an exclusive license to market and distribute Kreatech Biotechnology’s ULS labeling technologies in combination with its resonance light scattering products.

In addition, Qiagen acquired non-exclusive rights to develop and sell ULS products for labeling and detecting nucleic acids and proteins in microarray experiments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.